ArticlePharmacoEconomics2025

Cost-Effectiveness Analysis of Aztreonam-Avibactam (ATM-AVI) Versus Colistin + Meropenem (COL + MER) for the Treatment of Infections Caused by Metallo-β-Lactamase (MBL)-Producing Enterobacterales in Italy.

Marco Falcone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.